Skip to content
GovLens is in free beta — full access while we build. Join the beta →
← 🇳🇱 Tweede Kamer/NOTA N.A.V. HET (NADER/TWEEDE NADER/ENZ.) VERSLAGnl-doc-0d408e96-2d31-4b46-8fcf-2ee804a22408

Wijziging van de Wet geneesmiddelenprijzen in verband met een aanpassing van de referentielanden

Stage submittedUpdated 5mo ago

This procedure concerns an amendment to the Dutch Medicines Prices Act. The proposed changes aim to adjust the reference countries used for setting medicine prices. This amendment will affect pharmaceutical companies and potentially influence the prices of medicines available to patients in the Netherlands.

National vote coverage: Netherlands-only